Dignity Health January marks Healthy Weight Awareness Month, and with the new year, many are setting health and weight loss ...

The list prices of the top 25 drugs with the highest Medicare Part D spend that are not subject to drug price negotiations have increased by an average 98% since they hit the market, according to a ...

We should expect more sleep tech in 2025. CES proves the sleep industry isn't slowing down for a second. It's CES week, which ...

Medicare now covers Eli Lilly's Zepbound for obstructive sleep apnea, FDA-approved for obesity and sleep apnea treatment, ...

Paris Jackson says she is in recovery from heroin and alcohol addiction, announcing she has reached five years of sobriety ...

"Coverage for these weight-loss drugs has significant cost implications for employers, as a previous KFF analysis estimated ...

The global sleep AIDS market size was valued at $59,815.10 million in 2020, and is projected to reach $111,920.10 million by 2030, registering a CAGR of 6.9%. David Correa Allied Market Research +1 ...

Hims has become a leader in the weight loss treatment industry by offering access to men’s health solutions that are both ...

The U.S. FDA has approved Zepbound (tirzepatide) as the first prescription medication for the treatment of obstructive sleep apnea.

Weight-loss medication like Semaglutide and Tirzepatide has seen a rise in demand, causing a boom in sales. This exploding ...

John Firth, 45, and Aileen Cullinane, 35, were sleeping rough when a friend offered them a room for the night. The next ...

Tirzepatide is the active ingredient in Zepbound, the FDA approved prescription medicine for Obstructive Sleep Apnea.